Finger sensor guided fluids for skin health in older ICU patients
Part of Infections clinical trials.
This study tests if using a finger sensor to guide fluid therapy can prevent skin failure in older ICU patients with sepsis or shock. It compares usual care to personalized fluid management.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 65 years old or older.
- You have sepsis or another type of shock that needs large amounts of fluids quickly.
- You are expected to stay in the intensive care unit (ICU) for at least 3 days.
- You do not have a serious skin condition or blood vessel disease that could interfere with the study measurements.
- You do not have a condition that makes it unsafe to receive extra fluids, such as severe heart failure.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a personalized approach to giving fluids to patients with sepsis, a serious infection that can cause low blood pressure. The goal is to see if individualized fluid resuscitation improves outcomes compared to standard care.
This study tests a computer software that helps doctors decide how much fluid to give patients in septic shock. It aims to improve blood pressure and oxygen delivery without causing fluid overload.
This study tests whether using a non-invasive monitor to guide fluid and medication decisions helps people with sepsis recover better than standard care. It aims to improve blood flow and organ function without extra needles or procedures.
This study checks if a simple blood flow measurement can help predict which patients with sepsis are at higher risk of dying within 28 days. The goal is to see if this test can guide treatment decisions in the ICU.
This study looks at how well blood flows to your skin and tissues during sepsis in the ICU. Doctors will check your circulation and see if it relates to how you recover.
This trial compares the use of a simple ultrasound test of the lungs and heart to help doctors decide how much fluid to give adults with septic shock. The goal is to find the most accurate way to guide treatment, which could lead to better recovery.
Hear when a new Sepsis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.